Grindeks AS
GRD1R · Nasdaq Riga · Pharmaceuticals
About the company
Grindeks is an internationally operating Latvian pharmaceutical manufacturer headquartered in Riga, producing original drugs, generics, and active pharmaceutical ingredients. Its portfolio includes Mildronate (meldonium), a cardiovascular compound with significant exports to CIS markets. The company has subsidiaries in Estonia, Slovakia, and other countries.
| Exchange | Nasdaq Riga |
| Ticker | GRD1R |
| Sector | Pharmaceuticals |
| Indicative market cap USD | $130.00M |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
On its home market (Nasdaq Riga), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Nasdaq Riga — official exchange listing
Availability information only — not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in Latvia
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only — not investment advice. Verify with the exchange, the company's filings and your broker.